Mika Raitanen

1.4k total citations
36 papers, 1.1k citations indexed

About

Mika Raitanen is a scholar working on Surgery, Urology and Molecular Biology. According to data from OpenAlex, Mika Raitanen has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 8 papers in Urology and 6 papers in Molecular Biology. Recurrent topics in Mika Raitanen's work include Bladder and Urothelial Cancer Treatments (25 papers), Urinary and Genital Oncology Studies (17 papers) and Esophageal Cancer Research and Treatment (4 papers). Mika Raitanen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (25 papers), Urinary and Genital Oncology Studies (17 papers) and Esophageal Cancer Research and Treatment (4 papers). Mika Raitanen collaborates with scholars based in Finland, Sweden and Germany. Mika Raitanen's co-authors include Teuvo L.J. Tammela, Erkki Rintala, Pertti Rajala, Tapani Liukkonen, Eero Kaasinen, Risto Aine, O Lukkarinen, Jukka Kallio, Harri Juusela and Pentti Nieminen and has published in prestigious journals such as The Journal of Urology, British Journal of Cancer and Clinical Chemistry.

In The Last Decade

Mika Raitanen

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mika Raitanen Finland 19 822 232 230 203 153 36 1.1k
LaMont Barlow United States 16 488 0.6× 166 0.7× 420 1.8× 244 1.2× 319 2.1× 36 1.0k
Pertti Rajala Finland 14 656 0.8× 217 0.9× 208 0.9× 153 0.8× 95 0.6× 22 930
Thiagarajan Sreenivasan United Kingdom 6 607 0.7× 256 1.1× 139 0.6× 208 1.0× 126 0.8× 6 808
S. Hautmann Germany 16 1.0k 1.2× 388 1.7× 410 1.8× 173 0.9× 299 2.0× 52 1.5k
Thomas H. Stanisic United States 14 599 0.7× 188 0.8× 232 1.0× 169 0.8× 126 0.8× 32 959
J. Palou-Redorta Spain 12 1.6k 1.9× 525 2.3× 347 1.5× 307 1.5× 206 1.3× 21 1.8k
Madelon N.M. van der Aa Netherlands 12 947 1.2× 227 1.0× 402 1.7× 156 0.8× 188 1.2× 14 1.1k
Phyllis Hollander United States 7 1.0k 1.3× 164 0.7× 143 0.6× 417 2.1× 282 1.8× 13 1.2k
Pamela P. Griffin United States 19 1.2k 1.5× 433 1.9× 210 0.9× 281 1.4× 552 3.6× 36 1.7k
Jonathan Melquist United States 8 1.2k 1.4× 182 0.8× 479 2.1× 333 1.6× 408 2.7× 15 1.4k

Countries citing papers authored by Mika Raitanen

Since Specialization
Citations

This map shows the geographic impact of Mika Raitanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Raitanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Raitanen more than expected).

Fields of papers citing papers by Mika Raitanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Raitanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Raitanen. The network helps show where Mika Raitanen may publish in the future.

Co-authorship network of co-authors of Mika Raitanen

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Raitanen. A scholar is included among the top collaborators of Mika Raitanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Raitanen. Mika Raitanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murtola, Teemu J., Juha Koskimäki, Jarno Riikonen, et al.. (2023). Robot‐assisted versus three‐dimensional laparoscopic radical prostatectomy: 12‐month outcomes of a randomised controlled trial. British Journal of Urology. 132(5). 505–511. 3 indexed citations
2.
Murtola, Teemu J., et al.. (2022). Visual Analogue Scale (VAS) in the Evaluation of Functional Outcomes After Three-dimensional Laparoscopic Prostatectomy. Urology. 172. 121–125. 4 indexed citations
3.
Marttila, Timo, Riikka Järvinen, Tapani Liukkonen, et al.. (2016). Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non–Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study. European Urology. 70(2). 341–347. 25 indexed citations
4.
Raitanen, Mika, et al.. (2008). The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies. World Journal of Urology. 26(1). 45–50. 49 indexed citations
5.
Kylmälä, Timo, Hanna Tainio, Mika Raitanen, & Teuvo L.J. Tammela. (2003). Treatment of Postoperative Male Urinary Incontinence Using Transurethral Macroplastique Injections. Journal of Endourology. 17(2). 113–115. 24 indexed citations
6.
7.
Raitanen, Mika, Risto Aine, Erkki Rintala, et al.. (2002). Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis. European Urology. 41(3). 284–289. 169 indexed citations
8.
Raitanen, Mika, Eero Kaasinen, O Lukkarinen, et al.. (2001). Analysis of false-positive BTA stat test results in patients followed up for bladder cancer. Urology. 57(4). 680–684. 33 indexed citations
9.
Raitanen, Mika, et al.. (2001). Effect of Intravesical Instillations on the Human Complement Factor H Related Protein (BTA <i>stat</i>) Test. European Urology. 40(4). 422–426. 16 indexed citations
10.
Raitanen, Mika, Timo Marttila, Martti Nurmi, et al.. (2001). HUMAN COMPLEMENT FACTOR H RELATED PROTEIN TEST FOR MONITORING BLADDER CANCER. The Journal of Urology. 165(2). 374–377. 35 indexed citations
11.
Raitanen, Mika, Eevi Kaasinen, Esa Rintala, et al.. (2001). Prognostic utility of human complement factor H related protein test (the BTA stat®Test). British Journal of Cancer. 85(4). 552–556. 13 indexed citations
12.
Liukkonen, Tapani, P. Lipponen, Mika Raitanen, et al.. (2000). Evaluation of p21 WAF1/CIP1 and cyclin D 1 expression in the progression of superficial bladder cancer. Urological Research. 28(5). 285–292. 39 indexed citations
13.
Raitanen, Mika, Timo Marttila, Eero Kaasinen, et al.. (2000). SENSITIVITY OF HUMAN COMPLEMENT FACTOR H RELATED PROTEIN (BTA STAT) TEST AND VOIDED URINE CYTOLOGY IN THE DIAGNOSIS OF BLADDER CANCER. The Journal of Urology. 1689–1692. 1 indexed citations
14.
Raitanen, Mika, Timo Marttila, Eero Kaasinen, et al.. (2000). SENSITIVITY OF HUMAN COMPLEMENT FACTOR H RELATED PROTEIN (BTA STAT) TEST AND VOIDED URINE CYTOLOGY IN THE DIAGNOSIS OF BLADDER CANCER. The Journal of Urology. 163(6). 1689–1692. 34 indexed citations
15.
Liukkonen, Tapani, Pertti Rajala, Mika Raitanen, et al.. (1999). Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study. European Urology. 36(5). 393–400. 80 indexed citations
16.
17.
Raitanen, Mika. (1999). Specificity of Human Complement Factor H-Related Protein Test (Bard BTA stat Test). Scandinavian Journal of Urology and Nephrology. 33(4). 234–236. 13 indexed citations
18.
Raitanen, Mika, et al.. (1995). Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.. PubMed. 84(1). 37–41. 8 indexed citations
19.
Raitanen, Mika, Pentti Nieminen, & Teuvo L.J. Tammela. (1995). Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. British Journal of Urology. 76(4). 470–474. 41 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LaMont Barlow Breakdown of academic impact, for papers by Pertti Rajala Breakdown of academic impact, for papers by Thiagarajan Sreenivasan Breakdown of academic impact, for papers by S. Hautmann Breakdown of academic impact, for papers by Thomas H. Stanisic Breakdown of academic impact, for papers by J. Palou-Redorta Breakdown of academic impact, for papers by Madelon N.M. van der Aa Breakdown of academic impact, for papers by Phyllis Hollander Breakdown of academic impact, for papers by Pamela P. Griffin Breakdown of academic impact, for papers by Jonathan Melquist
Rankless by CCL
2026